TrialCancer immunology, immunotherapy : CII2003

Bcl-2 expression in metastatic malignant melanoma. Importance for the therapeutic efficacy of biochemotherapy.

Annika Håkansson et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.